Ledger.Open graph →
SEC Form D · Amendment · filed December 7, 2018

Paragon Biosciences Emalex Capital, Inc

Offering
$9.4M
Sold
$9.4M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NORTHBROOK, IL
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Jeffrey Aronin · Northbrook, ILDirectorPatrick Morris · Northbrook, ILExec · DirectorDarien Parhad · Northbrook, ILExecTimothy Cunniff · Northbrook, ILDirectorSophie Pibouin · COLUMBUS, OHExec · DirectorVishal Makhijani · San Francisco, CAExecRussell Middleton · San Francisco, CADirectorRoger Kahn · COLUMBUS, OHDirectorTom Marrel · Scottsdale, AZExecTanner Beckstrand · Bluffdale, UTDirectorNathan H. Pearl · San Francisco, CADirectorGeorge A. Kahle, Iii · Vero Beach, FLExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗